miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4

Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease

(2015) Jonathan A.R. Gordon et al.   BONE

MicroRNA-24 Regulates Osteogenic Differentiation via Targeting T-Cell Factor-1

(2015) Weigong Zhao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MiR-21 overexpression improves osteoporosis by targeting RECK

(2015) Weigong Zhao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats

(2015) Yanzhi Liu et al.   Clinical Interventions in Aging

Bone defects: Molecular and cellular therapeutic targets

(2014) Vincenzo Desiderio et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

(2014) Jing Y. Krzeszinski et al.   NATURE

Glucocorticoid-induced osteoporosis: who to treat with what agent?

(2014) René Rizzoli et al.   Nature Reviews Rheumatology

The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects

(2014) Marlies C van der Goes et al.   ARTHRITIS RESEARCH & THERAPY

Decreased histone deacetylase 4 is associated with human osteoarthritis cartilage degeneration by releasing histone deacetylase 4 inhibition of runt-related transcription factor-2 and increasing osteoarthritis-related genes: a novel mechanism of human osteoarthritis cartilage degeneration

(2014) Kun Cao et al.   ARTHRITIS RESEARCH & THERAPY

MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation

(2013) Jih-Yang Ko et al.   BONE

Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation

(2013) Amel Dudakovic et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives

(2013) Markus J Seibel et al.   Lancet Diabetes & Endocrinology

IGF-I 3′ Untranslated Region: Strain-Specific Polymorphisms and Motifs Regulating IGF-I in Osteoblasts

(2012) Spenser S. Smith et al.   ENDOCRINOLOGY

Epigenetic protein families: a new frontier for drug discovery

(2012) Cheryl H. Arrowsmith et al.   NATURE REVIEWS DRUG DISCOVERY

The conundrum of glucocorticoid-induced osteoporosis

(2012) Steven L. Teitelbaum   Nature Reviews Endocrinology

MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4

(2011) Ying-Jie Guan et al.   FASEB JOURNAL

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Glucocorticoid-Induced Bone Disease

(2011) Robert S. Weinstein   NEW ENGLAND JOURNAL OF MEDICINE

HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This Repression

(2010) Emi Shimizu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dosing-time dependent effect of dexamethasone on bone density in rats

(2009) Masaki Takahashi et al.   LIFE SCIENCES

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

(2008) Michael Haberland et al.   NATURE REVIEWS GENETICS